Glofitamab has the potential to offer a readily available, fixed-duration CD20xCD3 bispecific antibody treatment approach for people with aggressive lymphoma
Researchers found that the drug combination led to a sustained and tenfold increase in the production of CD8 T cells and natural killer cells
Lung cancer is the leading cause of cancer death in the USA, making up almost 25% of all cancer deaths
Perrigo expects to launch Omeprazole Minis later this year
The groundbreaking SPF technology is specifically designed and formulated to prevent sunburn or sun damage while allowing the passage of sufficient UVB light that our bodies use to naturally produce vitamin D
The centre works with active pharmaceutical ingredients (APIs) and can utilize innovative concepts with model APIs
The acquisition is subject to customary closing conditions and necessary regulatory approvals. The financial terms of the transaction are confidential
For the third straight year, Lumenis wins an award recognizing outstanding medical companies and technologies
The company has posted net loss of Rs. 460.21 crores for the Financial Year ended March 31, 2022.
The AI and technology upgrades allow doctors to choose their medical speciality and even spelling preferences to set their own speech model
Subscribe To Our Newsletter & Stay Updated
